Bain Capital Community Partnership - Boston (PM)
Select a Team Member
Select the team member who asked for your support in the fight to beat rare cancers. If you prefer to give to the team and not a specific team member, please click “Donate to Team” below.
100% of all donations support research at MSK.
- OR -
Donate to Team
Together, We Will Beat Rare Cancers!
Welcome to the Bain Capital Community Partnership Boston morning team’s fundraising page. We’re raising money for rare cancer research at Memorial Sloan Kettering Cancer Center (MSK) with Cycle for Survival, MSK’s official rare cancer fundraiser and your support would mean everything!
Rare cancer research is significantly underfunded. As MSK’s official rare cancer fundraiser, Cycle for Survival helps fill the gap. Due to the generosity of people like you, since 2013 Bain Capital has raised over $2.5M through Cycle for Survival. Funding has led to new FDA-approved drugs, innovative diagnostic technologies, lifesaving clinical trials, and state-of-the-art DNA sequencers.
If you are interested in making a tax-deductible gift, please click on the 'Donate' button above.
We need to keep the momentum going so that MSK doctors and scientists can continue to make lifesaving breakthroughs and more people with rare cancer can get the treatments they need. Your support will enable rapid new advances and bring hope to patients worldwide!
We are grateful for your consideration and support, thank you!


The Cycle for Survival Web page and e-mail are provided as a courtesy to participants to help them manage fundraising efforts for this event. Memorial Sloan Kettering Cancer Center or any of its affiliated organizations, or their officers, directors, agents, or employees do not control, nor are they responsible for, the contents of this Web page. Any views or information provided on this Web page are the sole responsibility of the participant. The participant's Web page may provide links to other Web sites and does not imply an endorsement by MSKCC, its affiliated organizations, their officers, directors, agents, and employees of the materials contained at those Web sites. |